Search for: "Vanda Pharmaceuticals, Inc. v. FDA" Results 1 - 10 of 10
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Vanda-lay Litigation Industries, Inc.: Taking Stock of Vanda Pharmaceuticals, Inc.’s Big Bets on Petitioning and Litigation Against FDA and the Federal Government
1 Oct 2024, 8:21 pm by Kurt R. Karst
VANDA PHARMACEUTICALS INC. v. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Vanda v. West-Ward. Hatch-Waxman issues AND inducement AND 101
14 Apr 2018, 11:46 am by Lawrence B. Ebert
” Ferring B.V. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Vanda Seeks Supreme Court Review on Lower Standard for Obviousness
23 Jan 2024, 3:43 am by Dennis Crouch
Vanda Pharmaceuticals Inc., v. [read post]
Patently-O - https://patentlyo.com
FDA Denies Vanda’s Citizen Petitions Regarding the Need for Braille Labeling for Tasimelteon Generics
17 Aug 2023, 9:00 pm by Kurt R. Karst
Tobolowsky —In January 2023, Vanda Pharmaceuticals, Inc. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Federal Circuit: Hardening the Line on Method-of-Treatment Claims
28 Mar 2019, 9:07 am by Dennis Crouch
See Vanda Pharmaceuticals Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
More of a Bad Thing? Thoughts on FDA’s Proposal to Extend the FDR Process to Withdrawals of Accelerated Approvals
12 Apr 2022, 6:14 pm by Kurt R. Karst
  See Vanda Pharmaceuticals, Inc. v. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
The Use of Mandated Public Disclosures of Clinical Trials as Prior Art Against Study Sponsors
16 Apr 2024, 8:42 am by Holman
Inc. v. [read post]
Patently-O - https://patentlyo.com
Obviousness: Is a Reasonable Expectation of Success Sufficient
19 Feb 2024, 12:55 pm by Dennis Crouch
by Dennis Crouch In Vanda v. [read post]
Patently-O - https://patentlyo.com
Medical Treatment Patent Claims Held Patentable Subject Matter Under the Alice/Mayo Section 101 Test
30 Apr 2019, 7:10 pm by Antoinette F. Konski
In Vanda Pharmaceuticals Inc. v. [read post]
Personalized Medicine Bulletin - https://www.foley.com/en/insights/blogs/personalized-medicine-bulletin
When is the use of a product a “substantial noninfringing use” for purposes of Section 271(c)?
11 Dec 2023, 7:43 am by Holman
Inc. v. [read post]
Patently-O - https://patentlyo.com